|
⚲
|
| Keyboard |
| Hatteras Venture Affiliates III LP
✚
|
|
|---|---|
| CIK # | 0001390738 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001390738] | |
| 4 | [0001390738] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Sell | 42 | $5.00 | 210 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 19,061 | $0.12 | 2,287 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Sell | 458 | $5.00 | 2,290 |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 1,731 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 1,731 | $0.12 | 208 |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 47,458 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 47,458 | $0.12 | 5,695 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Sell | 1,139 | $5.00 | 5,695 |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 4,309 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 4,309 | $0.12 | 517 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Sell | 104 | $5.00 | 520 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 41,414 | $0.12 | 4,970 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Sell | 994 | $5.00 | 4,970 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series 1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 52,690 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 1,683,420 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 150,000 | $5.00 | 750,000 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 52,690 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 266,481 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 137,513 | $5.00 | 687,565 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 150,612 | ||
| showing 20 of 50 most recent transactions | |||||